Abstract
Considerable controversy remains about whether triglycerides are an important risk factor for coronary heart disease (CHD). Virtually every data set looking at the univariate relationship of triglycerides to subsequent CHD has shown what we found in Framingham in the 5127, men and women free of cardiovascular disease at entry, followed for 30 years, using in this case measures of the very low density lipoproteins, the principal carrier of triglycerides, determined in an analytical ultracentrifuge as the Sf 20 – 400 lipoproteins by Dr. John Gofman (8) (Figure 1). This figure shows that the men and women with the highest triglycerides run the highest rates of CHD and the men and women with the lowest triglycerides run the lowest rates of CHD. On multivariate analysis this is an independent risk factor in women; it was not an independent risk factor in men after adjusting for HDL cholesterol. Not only are the triglycerides an independent risk factor in women but on likelihood ratio analysis they are a more powerful predictor of CHD in women than are the LDL cholesterols (9). Through the years in the Framingham Heart Study, triglycerides were measured in many ways: non-fasting, spun in the preparative ultracentifuge for one hour to remove chylomicrons, non-fasting, fasting for 12 to 14 hours.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Austin MA, Hreslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. (1988):JAMA, 260: 1917–1921.
Austin MA, King M-C, Vranizan KM, Krauss RM. (1990):Circulation,82:495–506.
Brewster DW, Bombick DW, Matsumura F. (1988):J Toxicology & Environ Health,25:495–507.
Carlson LA, Rosenhamer G. (l988):Acta Med Scand.,223: 405–418.
Castelli W. (l988):Canad. J. of Cardiol.,4:Suppl A:5A–10A.
Dean JD, Jones CJH, Hutchison SJ, Peters JR, Henderson AH. (1991):Lancet,i:456–457.
Frick MH, Elo O, Haapa K, et al. (1987):N Engl J Med.,317:1237–1245.
Gofman JW. (1956):Circulation,14:691–741.
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. (1977):Am J Med.,62:707–714.
Grundy SM, Mok HY, Zech L, et al. (1979):J. Clin Invest.,63: 1274–1283.
Kaplan N. (l989):Arch Int Med.,149:1514–1520.
Kissebah AH, Vydelingum N, Murray R, et al., (1982): J Clin Endocrinol Metabol.54:254–260.
Krauss RM, Burke DJ. (1982):J Lipid Res.,23:97–104.
Lovati MR, Galbussera M, Franceschini G, Weber G, Resi L, Tanganelli P, Sirtori CR. (1984):Toxicology and Appl Pharm.,75:91–97.
Packard CJ, Munro A, Lorimer AR, Gotto AM, Shephard J. (1984):J Clin Invest.,74:2178–2192.
Poapst M, Reardon M, Steiner G. (1985):Arteriosclerosis,5:381–390.
Reaven GM. (1988):Diabetes,37:1595–1607.
Sacks FM, Breslow JL. (1987):Arteriosclerosis,7:35–46.
Schonfeld G, Weidman SW, Witztum JL, Bowen RM. (1976): Metabolism: Clinical & Experimental,25:261–275.
Sniderman A, Wolfson C, Teng B, Franklin FA, Barchorik P, Kwiterovitch PO. (1982):Ann Intern Med.,97:833–839.
Williams RR, Hunt SC, Hopkins PN, et al. (1988):JAMA.259:3579–3586.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Castelli, W.P. (1992). Whither Triglycerides in the Cholesterol Campaign. In: Gotto, A.M., Lenfant, C., Paoletti, R., Soma, M. (eds) Multiple Risk Factors in Cardiovascular Disease. Medical Science Symposia Series, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2700-4_29
Download citation
DOI: https://doi.org/10.1007/978-94-011-2700-4_29
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5196-5
Online ISBN: 978-94-011-2700-4
eBook Packages: Springer Book Archive